What's in ITEL Telecomunicazioni Srl's pipeline?

ITEL Telecomunicazioni Srl has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with ITEL Telecomunicazioni Srl's portfolio?

Top competitors by shared drug class: Affiliated Hospital of Jiangnan University, Amsterdam UMC, location VUmc, Blue Earth Diagnostics, Brigham and Women's Hospital, Genzyme, a Sanofi Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/itel-telecomunicazioni-srl.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

ITEL Telecomunicazioni Srl — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ITEL Telecomunicazioni Srl pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Radiopharmaceutical 18F-JK-PSMA-7	Radiopharmaceutical 18F-JK-PSMA-7	phase 3	PSMA-targeted PET imaging agent	PSMA (prostate-specific membrane antigen)	Oncology
Radiopharmaceutical 18F-Fluorocholine	Radiopharmaceutical 18F-Fluorocholine	phase 3	Radiopharmaceutical	Choline transporter	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Affiliated Hospital of Jiangnan University · 1 shared drug class
Amsterdam UMC, location VUmc · 1 shared drug class
Blue Earth Diagnostics · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
Genzyme, a Sanofi Company · 1 shared drug class
Gustave Roussy, Cancer Campus, Grand Paris · 1 shared drug class
HTA Co., Ltd. · 1 shared drug class
IRCCS San Raffaele · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ITEL Telecomunicazioni Srl:

Cite this brief

Drug Landscape (2026). ITEL Telecomunicazioni Srl — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/itel-telecomunicazioni-srl. Accessed 2026-05-17.